• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    APX Acquisition Corp. I Reports 10-K Delinquency Notice

    6/5/24 1:33:00 PM ET
    $APXI
    Blank Checks
    Finance
    Get the next $APXI alert in real time by email

    NASHVILLE, Tenn., June 5, 2024 /PRNewswire/ -- APX Acquisition Corp. I (NASDAQ: APXI) ("Company"), a publicly traded special purpose acquisition company, today announced that it received a deficiency letter (the "Letter") on May 30, 2024 from the Listing Qualifications Department of The Nasdaq Stock Market ("Nasdaq"). The Letter notified the Company that since the Company had not yet filed its Annual Report on Form 10-K for the year ended December 31, 2023 (the "Form 10-K") and its Quarterly Report on Form 10-Q for the quarter ended March 31, 2024 (the "Form 10-Q"), the Company does not comply with Nasdaq's Listing Rule 5250(c)(1) relating to the Company's obligation to file periodic financial reports for continued listing. The Letter further stated that the Company has until July 29, 2024 to submit a plan (the "Plan") to regain compliance with respect to the delinquent reports. The Letter also stated that any staff exemption to allow the Company to regain compliance, if granted, will be limited to a maximum of 180 calendar days from the due date of the Form 10-K, or September 27, 2024.

    If Nasdaq does not accept the Plan, the Company will have the opportunity to appeal that decision to the Nasdaq Hearings Panel.

    The Company will continue to work with its auditors with the objective of filing the Form 10-K and the Form 10-Q as soon as practicable and will work diligently to submit the Plan promptly and take the necessary steps to regain compliance as soon as practicable.

    About APX Acquisition Corp. I 

    The Company is a special purpose acquisition company, led by serial SPAC sponsor Kyle Bransfield, formed for the purpose of effecting a business combination with one or more businesses or entities. While the Company may pursue an initial business combination in any industry, The Company intends to focus its search on companies in Spanish-speaking Latin American countries or companies outside of Latin America that provide goods and services to Spanish-speaking markets.

    Forward-Looking Statements

    This press release includes, and oral statements made from time to time by representatives of the Company may include, "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements regarding possible business combinations and the financing thereof, and related matters, as well as all other statements other than statements of historical fact included in this press release are forward-looking statements. When used in this press release, words such as "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "might," "plan," "possible," "potential," "predict," "project," "should," "would" and similar expressions, as they relate to the Company or the Company's management team, identify forward-looking statements. Such forward-looking statements in this press release include, but are not limited to, the Company's expectations about the timing of completion and filing of the Form 10-Q, statements related to the Company's Plan, and timing and actions taken to regain compliance with Nasdaq. Actual results could differ materially from those contemplated by the forward-looking statements as a result of certain factors detailed in the Company's filings with the SEC. All subsequent written or oral forward-looking statements attributable to the Company or persons acting on the Company's behalf are qualified in their entirety by this paragraph. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the "Risk Factors" section of the Company's registration statement and final prospectus relating to the Company's initial public offering filed with the SEC. Copies are available on the SEC's website at www.sec.gov. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by applicable law.

    Contacts:

    APx Acquisition Corp. I

    Kyle Bransfield

    Chief Executive Officer

    [email protected]

    Cision View original content:https://www.prnewswire.com/news-releases/apx-acquisition-corp-i-reports-10-k-delinquency-notice-302165134.html

    SOURCE APx Acquisition Corp. I

    Get the next $APXI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $APXI

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $APXI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    APX Acquisition Corp. I Announces Nasdaq Delisting Notification for Warrants and Units

    NASHVILLE, Tenn., Nov. 1, 2024 /PRNewswire/ -- As previously announced, on September 4, 2024, APX Acquisition Corp. I (NASDAQ: APXI) (the "Company"), received a written notice from the Listing Qualifications Department of The Nasdaq Stock Market ("Nasdaq") indicating that since the Company's aggregate market value of its outstanding warrants was less than $1 million, the Company was no longer in compliance with the Nasdaq Global Market continued listing criteria set forth in Listing Rule 5452(b)(C) (the "Rule"), which requires the Company to maintain an aggregate market value of its outstanding warrants of at least $1 million (the "Notice"). The Company subsequently submitted a plan to regai

    11/1/24 5:48:00 PM ET
    $APXI
    Blank Checks
    Finance

    APX Acquisition Corp. I Reports 10-K Delinquency Notice

    NASHVILLE, Tenn., June 5, 2024 /PRNewswire/ -- APX Acquisition Corp. I (NASDAQ: APXI) ("Company"), a publicly traded special purpose acquisition company, today announced that it received a deficiency letter (the "Letter") on May 30, 2024 from the Listing Qualifications Department of The Nasdaq Stock Market ("Nasdaq"). The Letter notified the Company that since the Company had not yet filed its Annual Report on Form 10-K for the year ended December 31, 2023 (the "Form 10-K") and its Quarterly Report on Form 10-Q for the quarter ended March 31, 2024 (the "Form 10-Q"), the Company does not comply with Nasdaq's Listing Rule 5250(c)(1) relating to the Company's obligation to file periodic financi

    6/5/24 1:33:00 PM ET
    $APXI
    Blank Checks
    Finance

    APx Acquisition Corp. I, OmnigenicsAI Corp and MultiplAI Health Ltd enter into Business Combination Agreement to create a global AI-driven genomics platform

    NASHVILLE, Tenn., March 26, 2024 /PRNewswire/ -- APx Acquisition Corp. I (NASDAQ:APXI) ("APx"), a publicly traded special purpose acquisition company, OmnigenicsAI Corp ("OmnigenicsAI"), a precision medicine company incubated by Bioceres Group PLC, and MultiplAI Health Ltd ("MultiplAI"), a UK-based AI-enabled preventive medicine company, have entered into a definitive Business Combination Agreement ("BCA") that, upon closing, would result in OmnigenicsAI becoming a publicly listed company. The transaction is expected to close mid-year, subject to the approval of APx's shareholders and other customary closing conditions and, upon closing, OmnigenicsAI's shares are expected to be listed on Nas

    3/26/24 8:25:00 AM ET
    $APXI
    Blank Checks
    Finance

    $APXI
    SEC Filings

    View All

    SEC Form SCHEDULE 13G filed by APx Acquisition Corp. I

    SCHEDULE 13G - APx Acquisition Corp. I (0001868573) (Subject)

    1/7/25 4:31:51 PM ET
    $APXI
    Blank Checks
    Finance

    Amendment: SEC Form SCHEDULE 13G/A filed by APx Acquisition Corp. I

    SCHEDULE 13G/A - APx Acquisition Corp. I (0001868573) (Subject)

    1/7/25 11:47:26 AM ET
    $APXI
    Blank Checks
    Finance

    SEC Form 8-K filed by APx Acquisition Corp. I

    8-K - APx Acquisition Corp. I (0001868573) (Filer)

    12/16/24 4:05:25 PM ET
    $APXI
    Blank Checks
    Finance

    $APXI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO Bransfield Kyle P disposed of 100,000 units of Class A ordinary shares and acquired 100,000 units of Class A ordinary shares (SEC Form 4)

    4 - APx Acquisition Corp. I (0001868573) (Issuer)

    7/31/24 9:45:03 PM ET
    $APXI
    Blank Checks
    Finance

    Bransfield Kyle P disposed of 800,000 units of Class A ordinary shares and acquired 800,000 units of Class A ordinary shares (SEC Form 4)

    4 - APx Acquisition Corp. I (0001868573) (Issuer)

    3/25/24 5:00:06 PM ET
    $APXI
    Blank Checks
    Finance

    Bransfield Kyle P converted options into 3,342,188 units of Class A ordinary shares (SEC Form 4)

    4 - APx Acquisition Corp. I (0001868573) (Issuer)

    2/8/24 9:05:08 PM ET
    $APXI
    Blank Checks
    Finance

    $APXI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by APx Acquisition Corp. I

    SC 13G - APx Acquisition Corp. I (0001868573) (Subject)

    11/14/24 8:51:50 PM ET
    $APXI
    Blank Checks
    Finance

    SEC Form SC 13G filed by APx Acquisition Corp. I

    SC 13G - APx Acquisition Corp. I (0001868573) (Subject)

    11/14/24 4:18:23 PM ET
    $APXI
    Blank Checks
    Finance

    Amendment: SEC Form SC 13G/A filed by APx Acquisition Corp. I

    SC 13G/A - APx Acquisition Corp. I (0001868573) (Subject)

    10/16/24 9:19:30 AM ET
    $APXI
    Blank Checks
    Finance